LPA Genotype (rs41272114)

Most of the attention around lipoprotein(a), or Lp(a), goes to the genetic changes that push it up. This test looks at one that pushes it down. The variant, rs41272114, sits in the LPA gene, the gene that builds the protein backbone of Lp(a), and it breaks that gene's instructions so the copy carrying it makes little or no working Lp(a).

That makes it one of the more reassuring results on a genetics report, but only partly. You have two copies of the LPA gene, one from each parent, and this variant switches off only the copy it sits on. The other copy keeps working, and depending on what you inherited there, your Lp(a) can still be low, average, or high. That is why this result never replaces an Lp(a) blood test.

What This Variant Actually Does

Your LPA gene is read in pieces that are stitched together before the protein is made. rs41272114 changes a single letter at one of the stitching points (a splice site) in a part of the gene called kringle IV type 8. Researchers showed in 1999 that this change makes cells stitch the message together incorrectly, producing a shortened apo(a) protein that cannot attach to its LDL-like particle to form Lp(a). What little is released is quickly broken down. Geneticists call this a null allele: a copy of the gene that contributes essentially nothing to your Lp(a) level.

Lp(a) is one of the most strongly inherited traits in human blood, with up to about 90 percent of the differences between people explained by genetics. Much of that comes from the size of the apo(a) protein each LPA copy makes: smaller versions are released efficiently and drive Lp(a) up, while larger versions make much less. This matters here, because rs41272114 tends to sit on the larger, already low-output versions of the gene. Switching off a copy that was making little Lp(a) to begin with has a modest effect, which is why the average drop is smaller than you might expect from a broken gene.

How Much It Lowers Lp(a)

In a 2022 review of LPA genetics, carrying this variant was associated with Lp(a) levels roughly 5 to 17 mg/dL lower on average. For context, the typical (median) Lp(a) in people of European ancestry is only about 10 to 12 mg/dL, but levels range from almost zero to over 300 mg/dL, and the people at real risk sit far above the median. A drop of 5 to 17 mg/dL can matter, but it does not turn a high Lp(a) into a low one.

The variant only affects the copy it sits on. If your other LPA copy makes a small, efficiently released apo(a), or carries an Lp(a)-raising variant such as rs10455872, your Lp(a) can still be elevated. People with two copies (T/T) have the break on both copies of the gene, and in the original 1999 study they had essentially no intact Lp(a) in their blood, a condition known as congenital Lp(a) deficiency.

Heart Disease Risk

Because Lp(a) promotes artery disease in proportion to how much of it you have, a variant that lowers Lp(a) from birth acts like a lifelong natural experiment. In the PROCARDIS study of 4,073 people with early coronary artery disease and 4,225 people without it, carriers of rs41272114 had lower Lp(a) and about 21 percent lower odds of coronary artery disease (odds ratio 0.79).

A larger 2016 analysis combining UK Biobank with large genetic consortia found the same direction with a smaller effect: carriers had about 12 percent lower odds of coronary heart disease (odds ratio 0.88). Across several LPA variants, the same study found that genetically lower Lp(a) tracked with lower risk of peripheral artery disease, stroke, heart failure, and aortic valve stenosis, and with no link to 31 other conditions, including type 2 diabetes and cancer.

What this means for you: carrying the variant tilts your odds slightly in your favor, through lower Lp(a). It does not offset high LDL cholesterol, high blood pressure, smoking, or diabetes, and it does not protect you if your Lp(a) is high anyway because of your other gene copy.

How Common It Is

rs41272114 is the most common Lp(a) null variant in people of European ancestry, accounting for roughly a quarter of all non-working LPA copies in that group. In the gnomAD v4.1 reference database, about 3.6 percent of LPA gene copies carry it, which works out to roughly 1 in 14 people of European ancestry carrying one copy. It is more common in people with Latin American ancestry (about 9 percent of gene copies) and rare in people of African or East Asian ancestry. Two copies (T/T) is uncommon, roughly 1 in 600 people in gnomAD.

How Results Are Reported

Your report shows the two DNA letters at this position, one inherited from each parent, printed on the forward strand of chromosome 6 (C or T). Scientific papers often describe the same change as G>A (c.4289+1G>A) because the LPA gene is read from the opposite strand; they are the same variant. ClinVar, the US public database of variant classifications, lists it as benign or likely benign, meaning it does not cause disease. Lowering Lp(a) is not harmful.

What this means for you: none of these three results tells you your Lp(a) level. Treat the genotype as context and the blood test as the answer.

The Blood Test Still Decides

The European Atherosclerosis Society (2022) and the National Lipid Association (2024) both recommend measuring Lp(a) in the blood at least once in every adult. The NLA treats levels below 75 nmol/L (30 mg/dL) as low risk, 75 to 125 nmol/L (30 to 50 mg/dL) as intermediate, and 125 nmol/L (50 mg/dL) or higher as high risk. A genotype at one position cannot place you in one of those groups; only the measurement can.

This variant is most useful as an explanation. If your Lp(a) came back low and you carry it, you know part of why. If your Lp(a) came back high even though you carry it, that points to your other LPA copy as the source, which is worth knowing when relatives decide whether to get their own Lp(a) checked.

Why You Only Need This Test Once

Your DNA does not change. Your rs41272114 genotype at 25 will be the same at 65, so there is no reason to repeat this test. Lp(a) itself is also largely set by your genes and stays fairly stable through adult life, so for most people a single blood measurement is enough. Your clinician may repeat it if the first result sits near a decision point or if you start a treatment aimed at lowering Lp(a).

What to Do With Your Result

Whatever your genotype, the next steps are the same, and they center on the blood test:

• Measure your actual Lp(a): if you have not had an Lp(a) blood test, get one. It is reported in nmol/L or mg/dL and is the number guidelines use.
• Do not read a carrier result as an all-clear: one copy lowers Lp(a) on average, but your other LPA copy can still produce a high level. Only the blood test rules that out.
• Keep managing the rest of your risk: LDL cholesterol, ApoB, blood pressure, blood sugar, and smoking still drive most cardiovascular risk, whatever your Lp(a) genotype.
• Point family members to the right test: if your Lp(a) is high, or early heart disease runs in your family, the most useful step for relatives is their own Lp(a) blood test.

Carrying this variant is good news on average, but it is a nudge, not a guarantee. The blood test is what tells you where you actually stand.